Suppr超能文献

胃蛋白酶抑制剂的抑制机制。

Pepstatin inhibition mechanism.

作者信息

Marciniszyn J, Hartsuck J A, Tang J

出版信息

Adv Exp Med Biol. 1977;95:199-210. doi: 10.1007/978-1-4757-0719-9_12.

Abstract

Pepstatin is a low molecular weight, potent inhibitor specific for acid proteases with a Ki value of about 10(-10)M for pepsin. The chemical structure of pepstatin is essentially a hexapeptide which contains two residues of an unusual amino acid, 4-amino-3-hydroxy-6-methylheptanoic acid (statine). The complete structure of pepstatin is isovaleryl-L-valyl-L-valyl-statyl-L-alanyl-statine. To study its mode of inhibition, we prepared several derivatives and measured their kinetics of inhibition. Both N-acetyl-statine and N-acetyl-alanyl-statine are competitive inhibitors for pepsin with Ki values of 1.2 x 10(-4)M and 5.65 x 10(-6)M, respectively. The Ki value for N-acetyl-valyl-statine is 4.8 x 10(-6)M. These statyl derivatives, therefore, are very strong inhibitors. The Ki value for N-acetyl-statine is 600-fold smaller than that of its structural analog N-acetyl-leucine. The derivative which contains two statyl residues in a tetrapeptide exhibits inhibitory properties which approach those of pepstatin itself. Other acid proteases, human pepsin, human gastricsin, renin, cathepsin D, the acid protease from R. chinensis and bovine chymosin, also are inhibited by pepstatin and its derivatives. We suggest that the statyl residue is responsible for the unusual inhibitory capability of pepstatin and that statine is an analog of the previously proposed transition state for catalysis by pepsin and other acid proteases.

摘要

胃蛋白酶抑制剂是一种低分子量的强效抑制剂,对酸性蛋白酶具有特异性,对胃蛋白酶的Ki值约为10^(-10)M。胃蛋白酶抑制剂的化学结构本质上是一种六肽,其中包含两个不寻常氨基酸4-氨基-3-羟基-6-甲基庚酸( statine)的残基。胃蛋白酶抑制剂的完整结构是异戊酰-L-缬氨酰-L-缬氨酰-statyl-L-丙氨酰-statine。为了研究其抑制模式,我们制备了几种衍生物并测量了它们的抑制动力学。N-乙酰基-statine和N-乙酰基-丙氨酰-statine都是胃蛋白酶的竞争性抑制剂,Ki值分别为1.2×10^(-4)M和5.65×10^(-6)M。N-乙酰基-缬氨酰-statine的Ki值为4.8×10^(-6)M。因此,这些statyl衍生物是非常强的抑制剂。N-乙酰基-statine的Ki值比其结构类似物N-乙酰基-亮氨酸小600倍。在四肽中含有两个statyl残基的衍生物表现出接近胃蛋白酶抑制剂本身的抑制特性。其他酸性蛋白酶,如人胃蛋白酶、人胃泌素、肾素、组织蛋白酶D、中华根霉的酸性蛋白酶和牛凝乳酶,也受到胃蛋白酶抑制剂及其衍生物的抑制。我们认为statyl残基是胃蛋白酶抑制剂具有异常抑制能力的原因,并且statine是先前提出的胃蛋白酶和其他酸性蛋白酶催化过渡态的类似物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验